Switch to:
Also traded in: Germany, USA

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.02
NYSE:UHS's Cash-to-Debt is ranked lower than
93% of the 210 Companies
in the Global Medical Care industry.

( Industry Median: 0.26 vs. NYSE:UHS: 0.02 )
Ranked among companies with meaningful Cash-to-Debt only.
NYSE:UHS' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 0.01 Max: 0.27
Current: 0.02
0
0.27
Equity-to-Asset 0.45
NYSE:UHS's Equity-to-Asset is ranked higher than
51% of the 205 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. NYSE:UHS: 0.45 )
Ranked among companies with meaningful Equity-to-Asset only.
NYSE:UHS' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.26  Med: 0.42 Max: 0.49
Current: 0.45
0.26
0.49
Interest Coverage 48.75
NYSE:UHS's Interest Coverage is ranked higher than
76% of the 217 Companies
in the Global Medical Care industry.

( Industry Median: 8.17 vs. NYSE:UHS: 48.75 )
Ranked among companies with meaningful Interest Coverage only.
NYSE:UHS' s Interest Coverage Range Over the Past 10 Years
Min: 4.46  Med: 8.5 Max: 78.52
Current: 48.75
4.46
78.52
Piotroski F-Score: 7
Altman Z-Score: 2.83
Beneish M-Score: -2.76
WACC vs ROIC
6.34%
10.90%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 9/10

vs
industry
vs
history
Operating Margin % 13.42
NYSE:UHS's Operating Margin % is ranked higher than
74% of the 208 Companies
in the Global Medical Care industry.

( Industry Median: 6.49 vs. NYSE:UHS: 13.42 )
Ranked among companies with meaningful Operating Margin % only.
NYSE:UHS' s Operating Margin % Range Over the Past 10 Years
Min: 7.71  Med: 11.64 Max: 13.93
Current: 13.42
7.71
13.93
Net Margin % 7.31
NYSE:UHS's Net Margin % is ranked higher than
67% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 4.33 vs. NYSE:UHS: 7.31 )
Ranked among companies with meaningful Net Margin % only.
NYSE:UHS' s Net Margin % Range Over the Past 10 Years
Min: 3.64  Med: 6.04 Max: 7.53
Current: 7.31
3.64
7.53
ROE % 16.42
NYSE:UHS's ROE % is ranked higher than
77% of the 193 Companies
in the Global Medical Care industry.

( Industry Median: 9.61 vs. NYSE:UHS: 16.42 )
Ranked among companies with meaningful ROE % only.
NYSE:UHS' s ROE % Range Over the Past 10 Years
Min: 11.67  Med: 16.42 Max: 19.9
Current: 16.42
11.67
19.9
ROA % 7.37
NYSE:UHS's ROA % is ranked higher than
74% of the 212 Companies
in the Global Medical Care industry.

( Industry Median: 3.57 vs. NYSE:UHS: 7.37 )
Ranked among companies with meaningful ROA % only.
NYSE:UHS' s ROA % Range Over the Past 10 Years
Min: 4.01  Med: 5.89 Max: 8.46
Current: 7.37
4.01
8.46
ROC (Joel Greenblatt) % 27.54
NYSE:UHS's ROC (Joel Greenblatt) % is ranked higher than
68% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 15.74 vs. NYSE:UHS: 27.54 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
NYSE:UHS' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 15.92  Med: 23.33 Max: 27.54
Current: 27.54
15.92
27.54
3-Year Revenue Growth Rate 8.00
NYSE:UHS's 3-Year Revenue Growth Rate is ranked lower than
51% of the 180 Companies
in the Global Medical Care industry.

( Industry Median: 8.20 vs. NYSE:UHS: 8.00 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
NYSE:UHS' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 4.6  Med: 13.5 Max: 18.7
Current: 8
4.6
18.7
3-Year EBITDA Growth Rate 6.60
NYSE:UHS's 3-Year EBITDA Growth Rate is ranked lower than
54% of the 157 Companies
in the Global Medical Care industry.

( Industry Median: 7.30 vs. NYSE:UHS: 6.60 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
NYSE:UHS' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -3.3  Med: 14.1 Max: 26.7
Current: 6.6
-3.3
26.7
3-Year EPS without NRI Growth Rate 14.30
NYSE:UHS's 3-Year EPS without NRI Growth Rate is ranked higher than
63% of the 131 Companies
in the Global Medical Care industry.

( Industry Median: 6.80 vs. NYSE:UHS: 14.30 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
NYSE:UHS' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -11.3  Med: 14.3 Max: 31
Current: 14.3
-11.3
31
GuruFocus has detected 3 Warning Signs with Universal Health Services Inc $NYSE:UHS.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» NYSE:UHS's 10-Y Financials

Financials (Next Earnings Date: 2017-02-28)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

UHS Guru Trades in Q1 2016

Paul Tudor Jones 3,517 sh (New)
Andreas Halvorsen 429,887 sh (New)
John Paulson 54,000 sh (New)
Jeremy Grantham 20,700 sh (+30.19%)
Lee Ainslie 966,544 sh (+21.45%)
Jim Simons 215,000 sh (+19.98%)
Robert Olstein 34,000 sh (+6.25%)
RS Investment Management 227,613 sh (+1.25%)
Chris Davis 97,650 sh (+0.18%)
Vanguard Health Care Fund 3,939,340 sh (unchged)
Larry Robbins Sold Out
Steven Cohen 19,800 sh (-2.46%)
Westport Asset Management 571,391 sh (-8.05%)
Ron Baron 197,664 sh (-26.79%)
Private Capital 140,550 sh (-35.87%)
Joel Greenblatt 166,650 sh (-56.58%)
» More
Q2 2016

UHS Guru Trades in Q2 2016

Ray Dalio 1,500 sh (New)
Lee Ainslie 2,768,938 sh (+186.48%)
Joel Greenblatt 334,501 sh (+100.72%)
Paul Tudor Jones 3,571 sh (+1.54%)
Vanguard Health Care Fund 3,939,340 sh (unchged)
Chris Davis Sold Out
Andreas Halvorsen Sold Out
John Paulson Sold Out
Ron Baron 195,584 sh (-1.05%)
Private Capital 121,825 sh (-13.32%)
RS Investment Management 184,694 sh (-18.86%)
Robert Olstein 24,000 sh (-29.41%)
Westport Asset Management 400,827 sh (-29.85%)
Jeremy Grantham 13,000 sh (-37.20%)
Jim Simons 108,100 sh (-49.72%)
Steven Cohen 2,700 sh (-86.36%)
» More
Q3 2016

UHS Guru Trades in Q3 2016

Jana Partners 1,273,646 sh (New)
Larry Robbins 950,390 sh (New)
Andreas Halvorsen 1,929,192 sh (New)
Jim Simons 248,900 sh (+130.25%)
Lee Ainslie 4,584,358 sh (+65.56%)
Robert Olstein 34,000 sh (+41.67%)
Vanguard Health Care Fund 3,939,340 sh (unchged)
Ray Dalio Sold Out
Jeremy Grantham Sold Out
Steven Cohen Sold Out
Private Capital 119,170 sh (-2.18%)
Ron Baron 189,684 sh (-3.02%)
Joel Greenblatt 295,558 sh (-11.64%)
Paul Tudor Jones 2,200 sh (-38.39%)
» More
Q4 2016

UHS Guru Trades in Q4 2016

Paul Tudor Jones 12,393 sh (+463.32%)
Larry Robbins 1,762,915 sh (+85.49%)
Robert Olstein 57,000 sh (+67.65%)
Jana Partners 2,051,970 sh (+61.11%)
Lee Ainslie 6,130,994 sh (+33.74%)
Vanguard Health Care Fund 4,527,240 sh (+14.92%)
Private Capital 109,139 sh (-8.42%)
Ron Baron 156,224 sh (-17.64%)
Joel Greenblatt 182,778 sh (-38.16%)
Andreas Halvorsen 350,693 sh (-81.82%)
Jim Simons 16,400 sh (-93.41%)
» More
» Details

Insider Trades

Latest Guru Trades with UHS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 622110    SIC: 8062
Compare:NYSE:DVA, OTCPK:RMSYF, NYSE:EVHC, NAS:WOOF, OTCPK:SKHCY, NYSE:MD, OTCPK:CAKFY, NAS:ACHC, NYSE:HLS, NYSE:CHE, OTCPK:LTGHY, NAS:LPNT, NAS:SCAI, NYSE:THC, NYSE:AMN, NYSE:SEM, NAS:AMED, NAS:PAHC, NAS:SGRY, NYSE:CYH » details
Traded in other countries:UHS.Germany, UHID.USA,
Universal Health Services Inc, through its subsidiaries is engaged in the business of owning and operating acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers and radiation oncology centers.

Universal Health Services Inc is a Delaware corporation organized in 1979. The Company through its subsidiaries is engaged in the business of owning and operating, acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers and radiation oncology centers. It owned and/or operated 24 inpatient acute care hospitals, 3 free-standing emergency departments and 213 inpatient and 16 outpatient behavioral health care facilities located in 37 states, Washington, D.C., the United Kingdom, Puerto Rico and the U.S. Services provided by hospitals include general & specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services and behavioral health services. It provides capital resources as well as management services to facilities, including central purchasing, information services, finance & control systems, facilities planning, physician recruitment services, administrative personnel management, marketing and public relations. Its reportable operating segments consist of acute care hospital services and behavioral health care services. The Other segment includes centralized services including information services, purchasing, reimbursement, accounting, taxation, legal, advertising, design & construction and patient accounting as well as the operating results for its other operating entities including outpatient surgery and radiation centers. All of the Company's acute care hospitals and its behavioral health centers are certified as providers of Medicare & Medicaid services by the appropriate governmental authorities. Medicare is a federal program that provides certain hospital and medical insurance benefits to persons aged 65 and over, some disabled persons and persons with end-stage renal disease. Medicaid is a joint federal-state funded health care benefit program that is administered by the states to provide benefits to qualifying individuals who are unable to afford care state Medicaid payments are made under a PPS-like system, or under programs that negotiate payment levels with individual hospitals. Its hospitals also provide services to individuals covered by private health care insurance. Private insurance carriers typically make direct payments to hospitals or, in some cases, reimburse their policy holders, based upon the particular hospital's established charges and the particular coverage provided in the insurance policy. Its hospitals provide services to individuals that do not have any form of health care coverage. Such patients are evaluated, at the time of service or shortly thereafter, for their ability to pay based upon federal and state poverty guidelines, qualifications for Medicaid or other state assistance programs, as well as its local hospital's indigent and charity care policy. It faces competition for acquisition candidates mainly from other for-profit health care companies, as well

Ratios

vs
industry
vs
history
PE Ratio 17.74
UHS's PE Ratio is ranked higher than
71% of the 160 Companies
in the Global Medical Care industry.

( Industry Median: 25.10 vs. UHS: 17.74 )
Ranked among companies with meaningful PE Ratio only.
UHS' s PE Ratio Range Over the Past 10 Years
Min: 8.1  Med: 15.02 Max: 25.04
Current: 17.74
8.1
25.04
Forward PE Ratio 15.75
UHS's Forward PE Ratio is ranked higher than
77% of the 69 Companies
in the Global Medical Care industry.

( Industry Median: 19.72 vs. UHS: 15.75 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 17.74
UHS's PE Ratio without NRI is ranked higher than
74% of the 159 Companies
in the Global Medical Care industry.

( Industry Median: 25.91 vs. UHS: 17.74 )
Ranked among companies with meaningful PE Ratio without NRI only.
UHS' s PE Ratio without NRI Range Over the Past 10 Years
Min: 8.26  Med: 15.23 Max: 27.86
Current: 17.74
8.26
27.86
Price-to-Owner-Earnings 12.20
UHS's Price-to-Owner-Earnings is ranked higher than
82% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 27.14 vs. UHS: 12.20 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
UHS' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 7.73  Med: 14.66 Max: 186.83
Current: 12.2
7.73
186.83
PB Ratio 2.78
UHS's PB Ratio is ranked lower than
57% of the 192 Companies
in the Global Medical Care industry.

( Industry Median: 2.40 vs. UHS: 2.78 )
Ranked among companies with meaningful PB Ratio only.
UHS' s PB Ratio Range Over the Past 10 Years
Min: 1.01  Med: 2.13 Max: 3.54
Current: 2.78
1.01
3.54
PS Ratio 1.30
UHS's PS Ratio is ranked higher than
54% of the 206 Companies
in the Global Medical Care industry.

( Industry Median: 1.46 vs. UHS: 1.30 )
Ranked among companies with meaningful PS Ratio only.
UHS' s PS Ratio Range Over the Past 10 Years
Min: 0.33  Med: 0.78 Max: 1.68
Current: 1.3
0.33
1.68
Price-to-Free-Cash-Flow 13.45
UHS's Price-to-Free-Cash-Flow is ranked higher than
74% of the 94 Companies
in the Global Medical Care industry.

( Industry Median: 23.37 vs. UHS: 13.45 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
UHS' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 8.37  Med: 14.41 Max: 325.73
Current: 13.45
8.37
325.73
Price-to-Operating-Cash-Flow 9.41
UHS's Price-to-Operating-Cash-Flow is ranked higher than
70% of the 135 Companies
in the Global Medical Care industry.

( Industry Median: 13.84 vs. UHS: 9.41 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
UHS' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 3.21  Med: 8.39 Max: 23.76
Current: 9.41
3.21
23.76
EV-to-EBIT 13.27
UHS's EV-to-EBIT is ranked higher than
76% of the 145 Companies
in the Global Medical Care industry.

( Industry Median: 19.61 vs. UHS: 13.27 )
Ranked among companies with meaningful EV-to-EBIT only.
UHS' s EV-to-EBIT Range Over the Past 10 Years
Min: 6.2  Med: 11.3 Max: 20
Current: 13.27
6.2
20
EV-to-EBITDA 9.87
UHS's EV-to-EBITDA is ranked higher than
75% of the 157 Companies
in the Global Medical Care industry.

( Industry Median: 14.11 vs. UHS: 9.87 )
Ranked among companies with meaningful EV-to-EBITDA only.
UHS' s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.3  Med: 7.8 Max: 12.3
Current: 9.87
4.3
12.3
PEG Ratio 1.50
UHS's PEG Ratio is ranked higher than
76% of the 85 Companies
in the Global Medical Care industry.

( Industry Median: 2.76 vs. UHS: 1.50 )
Ranked among companies with meaningful PEG Ratio only.
UHS' s PEG Ratio Range Over the Past 10 Years
Min: 0.41  Med: 1.06 Max: 4.09
Current: 1.5
0.41
4.09
Shiller PE Ratio 29.90
UHS's Shiller PE Ratio is ranked higher than
56% of the 45 Companies
in the Global Medical Care industry.

( Industry Median: 30.81 vs. UHS: 29.90 )
Ranked among companies with meaningful Shiller PE Ratio only.
UHS' s Shiller PE Ratio Range Over the Past 10 Years
Min: 10.14  Med: 21.74 Max: 40.68
Current: 29.9
10.14
40.68
Current Ratio 1.24
UHS's Current Ratio is ranked higher than
55% of the 201 Companies
in the Global Medical Care industry.

( Industry Median: 1.20 vs. UHS: 1.24 )
Ranked among companies with meaningful Current Ratio only.
UHS' s Current Ratio Range Over the Past 10 Years
Min: 0.97  Med: 1.56 Max: 1.98
Current: 1.24
0.97
1.98
Quick Ratio 1.15
UHS's Quick Ratio is ranked higher than
55% of the 201 Companies
in the Global Medical Care industry.

( Industry Median: 1.07 vs. UHS: 1.15 )
Ranked among companies with meaningful Quick Ratio only.
UHS' s Quick Ratio Range Over the Past 10 Years
Min: 0.9  Med: 1.43 Max: 1.78
Current: 1.15
0.9
1.78
Days Inventory 41.87
UHS's Days Inventory is ranked lower than
75% of the 156 Companies
in the Global Medical Care industry.

( Industry Median: 16.39 vs. UHS: 41.87 )
Ranked among companies with meaningful Days Inventory only.
UHS' s Days Inventory Range Over the Past 10 Years
Min: 8.44  Med: 10.33 Max: 44.68
Current: 41.87
8.44
44.68
Days Sales Outstanding 50.00
UHS's Days Sales Outstanding is ranked lower than
61% of the 170 Companies
in the Global Medical Care industry.

( Industry Median: 44.02 vs. UHS: 50.00 )
Ranked among companies with meaningful Days Sales Outstanding only.
UHS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 42.28  Med: 52.47 Max: 62.41
Current: 50
42.28
62.41

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 0.32
UHS's Dividend Yield % is ranked lower than
95% of the 239 Companies
in the Global Medical Care industry.

( Industry Median: 1.59 vs. UHS: 0.32 )
Ranked among companies with meaningful Dividend Yield % only.
UHS' s Dividend Yield % Range Over the Past 10 Years
Min: 0.17  Med: 0.46 Max: 0.99
Current: 0.32
0.17
0.99
Dividend Payout Ratio 0.06
UHS's Dividend Payout Ratio is ranked higher than
99% of the 141 Companies
in the Global Medical Care industry.

( Industry Median: 0.39 vs. UHS: 0.06 )
Ranked among companies with meaningful Dividend Payout Ratio only.
UHS' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.04  Med: 0.06 Max: 0.1
Current: 0.06
0.04
0.1
3-Year Dividend Growth Rate 26.00
UHS's 3-Year Dividend Growth Rate is ranked higher than
75% of the 73 Companies
in the Global Medical Care industry.

( Industry Median: 14.50 vs. UHS: 26.00 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
UHS' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 0 Max: 58.7
Current: 26
0
58.7
Forward Dividend Yield % 0.32
UHS's Forward Dividend Yield % is ranked lower than
97% of the 235 Companies
in the Global Medical Care industry.

( Industry Median: 1.58 vs. UHS: 0.32 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 0.62
UHS's 5-Year Yield-on-Cost % is ranked lower than
87% of the 304 Companies
in the Global Medical Care industry.

( Industry Median: 2.28 vs. UHS: 0.62 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
UHS' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.33  Med: 0.9 Max: 1.93
Current: 0.62
0.33
1.93
3-Year Average Share Buyback Ratio -0.20
UHS's 3-Year Average Share Buyback Ratio is ranked higher than
79% of the 123 Companies
in the Global Medical Care industry.

( Industry Median: -2.50 vs. UHS: -0.20 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
UHS' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -1.4  Med: 1.8 Max: 3.6
Current: -0.2
-1.4
3.6

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 15.67
UHS's Price-to-Tangible-Book is ranked lower than
94% of the 143 Companies
in the Global Medical Care industry.

( Industry Median: 3.26 vs. UHS: 15.67 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
UHS' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.18  Med: 4.63 Max: 317.57
Current: 15.67
2.18
317.57
Price-to-Intrinsic-Value-Projected-FCF 1.01
UHS's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
75% of the 96 Companies
in the Global Medical Care industry.

( Industry Median: 1.76 vs. UHS: 1.01 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
UHS' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.74  Med: 1.15 Max: 33.96
Current: 1.01
0.74
33.96
Price-to-Intrinsic-Value-DCF (Earnings Based) 0.67
UHS's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked higher than
93% of the 30 Companies
in the Global Medical Care industry.

( Industry Median: 1.84 vs. UHS: 0.67 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 1.69
UHS's Price-to-Median-PS-Value is ranked lower than
80% of the 179 Companies
in the Global Medical Care industry.

( Industry Median: 1.04 vs. UHS: 1.69 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
UHS' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.49  Med: 1.11 Max: 2.13
Current: 1.69
0.49
2.13
Price-to-Peter-Lynch-Fair-Value 2.72
UHS's Price-to-Peter-Lynch-Fair-Value is ranked lower than
57% of the 46 Companies
in the Global Medical Care industry.

( Industry Median: 2.32 vs. UHS: 2.72 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
UHS' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.43  Med: 1.31 Max: 3.63
Current: 2.72
0.43
3.63
Price-to-Graham-Number 3.52
UHS's Price-to-Graham-Number is ranked lower than
69% of the 100 Companies
in the Global Medical Care industry.

( Industry Median: 2.31 vs. UHS: 3.52 )
Ranked among companies with meaningful Price-to-Graham-Number only.
UHS' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.97  Med: 1.95 Max: 12.53
Current: 3.52
0.97
12.53
Earnings Yield (Greenblatt) % 7.50
UHS's Earnings Yield (Greenblatt) % is ranked higher than
81% of the 185 Companies
in the Global Medical Care industry.

( Industry Median: 4.10 vs. UHS: 7.50 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
UHS' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 5  Med: 8.9 Max: 16.1
Current: 7.5
5
16.1
Forward Rate of Return (Yacktman) % 12.38
UHS's Forward Rate of Return (Yacktman) % is ranked higher than
59% of the 116 Companies
in the Global Medical Care industry.

( Industry Median: 10.28 vs. UHS: 12.38 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
UHS' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 9.8  Med: 18.6 Max: 28
Current: 12.38
9.8
28

More Statistics

Revenue (TTM) (Mil) $9,606
EPS (TTM) $ 7.10
Beta0.75
Short Percentage of Float2.69%
52-Week Range $99.72 - 139.77
Shares Outstanding (Mil)96.95

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 10,537 11,200 11,932
EPS ($) 7.24 7.93 8.76
EPS without NRI ($) 7.24 7.93 8.76
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($) 0.40 0.40 0.40
» More Articles for NYSE:UHS

Headlines

Articles On GuruFocus.com
Steven Romick Spots Next Area of Interest, Health Care Jan 13 2017 
Can Universal Health Services Power Past the Political Turbulence? Nov 30 2016 
Andreas Halvorsen’s Top 3 New Holdings Nov 16 2016 
Low P/S Stocks: The Travelers, AIG Sep 20 2016 
Westport's Top 7 Transactions in 2nd Quarter Were Reductions Sep 06 2016 
Healthcare Dividend Growth Stocks: Part 1 Aug 04 2016 
Westport Funds' Final Quarterly Commentary Jul 19 2016 
Quality Guru Stocks Include Amgen, Comcast Apr 21 2016 
Westport Trims Nearly 39% of Stakes in Portfolio Feb 12 2016 
Westport Select Cap Fund Third Quarter Commentary Oct 16 2015 

More From Other Websites
DEADLINE TOMORROW FOR UHS INVESTORS: Khang & Khang LLP Announces Securities Class Action Lawsuit... Feb 20 2017
DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against... Feb 20 2017
UNIVERSAL HEALTH 96 HOUR DEADLINE ALERT: APPROXIMATELY 96 HOURS REMAIN; FORMER LOUISIANA ATTORNEY... Feb 17 2017
UHS IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against... Feb 17 2017
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in... Feb 17 2017
Moody's Jumps into Action as Aetna-Humana Deal Fails Feb 17 2017
UnitedHealth Hits 52-Week High on Solid Results, SCAI Deal Feb 17 2017
SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Universal... Feb 17 2017
UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Shareholders of Universal Health Services, Inc. of... Feb 17 2017
U.S. hospital stocks start 2017 strong as some Obamacare fears ease Feb 15 2017
UHS IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against... Feb 14 2017
Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against... Feb 14 2017
IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against... Feb 14 2017
EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Universal Health... Feb 14 2017
UHS INVESTORS NOTICE: Lieff Cabraser Reminds Investors of Deadline in Class Action Against Universal... Feb 14 2017
UHS IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against... Feb 13 2017
UHS SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving... Feb 13 2017
INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Universal Health... Feb 13 2017
DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against... Feb 13 2017
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in... Feb 13 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)